When Your Surgeons Adopt ‘Smart’ AI It Isn’t Actually Smart

Mar 24, 2026 | by Brad Bichey

What Medical Device Executives Need to Know About AI Adoption and Its Impact On Sales

In medtech, you live by the numbers. Conversion rates. Pipeline velocity. Case volume.

But when it comes to AI, many of your surgeons are making decisions without the same rigor they’d apply to the evaluation of the medical devices they use.

Let’s change that.

Because AI can — and should — be graded just like any other performance system. Two key metrics tell you whether AI is actually helping your teams and your surgeons work smarter… or silently draining efficiency from your sales pipeline:

The F1 Score and Cohen’s Kappa

F1 Score: Think of It Like Your Surgeons’s Conversion Rate

The F1 score tells you how well AI being used balances accuracy and coverage — or in business terms, how effectively it finds qualified leads without wasting time on the wrong ones.

Here’s the breakdown:

  • Precision = When the AI flags a “referral,” how often is it right?
  • Recall = Of all real referrals, how many did it catch?

The F1 combines both.

Higher F1 = Fewer misses + fewer false alarms.

It’s your AI’s signal-to-noise ratio — how well it focuses your surgeon’s attention where it matters.

Cohen’s Kappa: Your “Surgical Alignment” Score

Here’s where the real insight lives.

Cohen’s Kappa (κ) measures how closely an AI’s decisions agree with clinical reasoning — adjusted for random chance.

  • κ = 1.0 → Perfect agreement
  • κ = 0.0 → Random guessing
  • κ = 0.43 → Moderate agreement

That last one isn’t theoretical.

A leading EHR’s AI scored κ = 0.43 when classifying ENT referrals — the lifeblood of surgical and device sales.

Translation: the AI only agrees with real clinician judgment 43% of the time. That’s like having a CRM algorithm that can’t agree with your reps on which leads are actually high-priority.

The result? Lost efficiency. Wasted follow-up. Slower surgical flow… And an invisible drag on revenue.

The Hidden Efficiency Block in EHR AI

Across the country, EHR vendors are rolling out “AI assistants” built on generic datasets that have little to do with specialty surgical care.

These AI solutions sound great in demos… but in practice:

  • Over-triage → Too many false positives clog workflows.
  • Under-triage → Real referrals get missed.
  • Disengagement → Clinicians lose trust and tune out.

A Kappa of 0.43 doesn’t just mean moderate disagreement — it means misalignment with how the surgical practice actually works.

That’s the hidden tax of generic AI. Every false event adds clicks, frustration, and delays to the surgical pipeline.

Every missed case costs you a sales opportunity.

The Opportunity: Medtech Can Lead Here

Here’s the good news — you’re uniquely positioned to fix this.

Medical device executives already understand:

  • What drives surgeon engagement
  • Where bottlenecks live
  • How to tie data back to real outcomes

Now imagine channeling that expertise into AI that truly aligns with clinical workflows.

That means:

  • Partnering with specialty-trained surgeons and AI builders
  • Demanding transparency with F1 and Kappa metrics
  • Supporting domain-specific validation, not “one-size-fits-all” AI

This is where the next generation of value-added partnerships will be built — not around more EHR features, but around trust and efficiency.

Bottom Line

AI in healthcare isn’t magic — it’s measurable. And the same way you measure rep performance or marketing ROI, you can measure whether AI is truly pulling its weight with your best surgeons.

Next time you hear an “AI-powered” pitch, ask:

  • What’s your F1 score?
  • What’s your Kappa?
  • How well does it agree with real clinical decision-making?

Because in this new era, AI that aligns with surgeons is AI that works.

And the leaders who learn to measure it and use it alongside their surgeons will define the competitive edge of tomorrow.

Fire up!